Caris Science, Inc.
Clinical trials sponsored by Caris Science, Inc., explained in plain language.
Precision medicine company offering molecular profiling services.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New genetic test aims to sharpen blood cancer diagnosis
Diagnosis Recruiting nowThis study looks at a new genetic test called Caris Chromoseq for people with certain blood cancers (acute myeloid leukemia, myelodysplastic syndrome, or myeloproliferative neoplasms). The test scans the entire genome to help classify the cancer and guide risk assessment. Researc…
Sponsor: Caris Science, Inc. • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Massive cancer biobank aims to fuel precision medicine breakthroughs
Knowledge-focused Recruiting nowThis study is creating a large collection of blood and tissue samples from 100,000 adults with cancer. The samples and medical information will be stored and shared with researchers to develop better tests and treatments. The goal is to advance precision medicine and improve earl…
Sponsor: Caris Science, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC